Table 2.

Comparison of the initial SLLs between MELAS‐mtND and MELAS‐A3243G patients.

SLLs	MELAS‐mtND	MELAS‐A3243G	p Value
n	18	49
Nonclassic SLLs	12/18, 66.7%	6/49, 12.2%	<0.001
Frontal lobe	2/18, 11.1%	5/49, 10.2%	>0.999
Parietal lobe	7/18, 38.9%	19/49, 38.8%	0.993
Temporal lobe	4/18, 22.2%	32/49, 65.3%	0.002
Occipital lobe	5/18, 27.8%	27/49, 55.1%	0.047
Insular	1/18, 5.6%	3/49, 6.1%	>0.999
Cerebellum	1/18, 5.6%	2/49, 4.1%	>0.999
Basal ganglion	2/18, 11.1%	1/49, 2.0%	0.174
Brain stem	0/18, 0	0/49, 0	>0.999

SLLs, stroke‐like lesions.